Design, Synthesis and Antiparasitic Evaluation of Click Phospholipids.
Leishmania donovani
Leishmania infantum
Trypanosoma brucei
Trypanosoma cruzi
antiparasitic activity
ether phospholipids
heterocyclic rings
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
10 Jul 2021
10 Jul 2021
Historique:
received:
01
06
2021
revised:
05
07
2021
accepted:
07
07
2021
entrez:
24
7
2021
pubmed:
25
7
2021
medline:
14
9
2021
Statut:
epublish
Résumé
A library of seventeen novel ether phospholipid analogues, containing 5-membered heterocyclic rings (1,2,3-triazolyl, isoxazolyl, 1,3,4-oxadiazolyl and 1,2,4-oxadiazolyl) in the lipid portion were designed and synthesized aiming to identify optimised miltefosine analogues. The compounds were evaluated for their in vitro antiparasitic activity against
Identifiants
pubmed: 34299479
pii: molecules26144204
doi: 10.3390/molecules26144204
pmc: PMC8305768
pii:
doi:
Substances chimiques
Antiparasitic Agents
0
Phospholipids
0
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Seventh Framework Programme
ID : 603240
Références
PLoS Negl Trop Dis. 2020 Jan 30;14(1):e0008001
pubmed: 31999732
Antimicrob Agents Chemother. 2005 Nov;49(11):4616-21
pubmed: 16251303
Int J Parasitol Drugs Drug Resist. 2018 Aug;8(2):194-202
pubmed: 29631127
PLoS Negl Trop Dis. 2016 May 12;10(5):e0004546
pubmed: 27171166
Org Biomol Chem. 2005 Aug 7;3(15):2824-31
pubmed: 16032360
Clin Infect Dis. 2012 Aug;55(4):543-50
pubmed: 22573856
Rev Infect Dis. 1985 Sep-Oct;7(5):625-34
pubmed: 3903942
Expert Rev Anti Infect Ther. 2009 Mar;7(2):157-63
pubmed: 19254164
Bioorg Med Chem Lett. 2010 Sep 15;20(18):5484-7
pubmed: 20719503
Antimicrob Agents Chemother. 1998 Dec;42(12):3097-102
pubmed: 9835497
Mini Rev Med Chem. 2012 Jul;12(8):789-801
pubmed: 22512560
Trans R Soc Trop Med Hyg. 2002 Apr;96 Suppl 1:S127-9
pubmed: 12055825
Parasitology. 2017 Nov;144(13):1718-1725
pubmed: 28831945
Infect Control Hosp Epidemiol. 1991 Jun;12(6):375-82
pubmed: 2071882
Am J Trop Med Hyg. 2017 Nov;97(5):1289-1303
pubmed: 29016289
Med Microbiol Immunol. 2016 Oct;205(5):449-58
pubmed: 27283847
Org Biomol Chem. 2004 Apr 21;2(8):1199-212
pubmed: 15064799
Exp Parasitol. 2013 Sep;135(1):153-65
pubmed: 23845259
Ther Clin Risk Manag. 2007 Oct;3(5):733-40
pubmed: 18472998
Proc Natl Acad Sci U S A. 1989 Apr;86(8):2607-11
pubmed: 2704738
Trans R Soc Trop Med Hyg. 1988;82(1):69-72
pubmed: 2845611
J Med Chem. 1996 Jun 21;39(13):2609-14
pubmed: 8691459
Drug Discov Today. 2017 Oct;22(10):1572-1581
pubmed: 28676407
Int J Parasitol Drugs Drug Resist. 2012 Mar 03;2:262-70
pubmed: 24533287
J Org Chem. 2009 Feb 20;74(4):1454-63
pubmed: 19159194
Curr Opin Infect Dis. 2012 Dec;25(6):695-702
pubmed: 23147810
Exp Parasitol. 2019 Nov;206:107730
pubmed: 31494215
Mini Rev Med Chem. 2014 Apr;14(4):355-69
pubmed: 24678879
Int J Parasitol Drugs Drug Resist. 2020 Apr;12:7-17
pubmed: 31862616
J Infect Dis. 2007 Aug 15;196(4):591-8
pubmed: 17624846
Cancer Chemother Pharmacol. 2008 Jul;62(2):321-9
pubmed: 17922125
Trends Parasitol. 2003 Nov;19(11):502-8
pubmed: 14580961
Eur J Med Chem. 2017 Sep 8;137:292-309
pubmed: 28605676
J Med Chem. 2008 Feb 28;51(4):897-908
pubmed: 18220332
Curr Pharm Des. 2021;27(15):1790-1806
pubmed: 33302850
Lancet Neurol. 2013 Feb;12(2):186-94
pubmed: 23260189
J Infect Dev Ctries. 2015 Jul 04;9(6):588-96
pubmed: 26142667
Cancer Chemother Pharmacol. 2011 Dec;68(6):1537-46
pubmed: 21526352
Lancet. 2018 Sep 15;392(10151):951-970
pubmed: 30126638
PLoS Negl Trop Dis. 2012;6(10):e1859
pubmed: 23145192
J Am Chem Soc. 2005 Jan 12;127(1):210-6
pubmed: 15631470
J Med Chem. 2003 Feb 27;46(5):755-67
pubmed: 12593656
Methods Mol Biol. 2019;1971:249-263
pubmed: 30980308